John Occhino, MD
Urogynecology and Reconstructive Pelvic Surgery · Rochester, MNNPI 1043421860
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,998 of the $6,263 with a category attached, or 79.8%. 9 manufacturers reported payments, led by Axonics, Inc. at 33.4% of the total. Reporting peaked in 2023 at $1,777 and has fallen 77.6% since, to $398 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $102.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- AbbVie$1K
- Boston Scientific$817
- Medtronic$756
- Caldera Medical, Inc$727
- Coloplast$471
- plus $163 from 3 others
What the payments were for
- Consulting fees$1,23820%
- Food & beverage$4,99880%
- Gifts$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 24 | $2,091 |
| AbbVie(2 entities) | 3 | $1,238 |
| Boston Scientific | 8 | $817 |
| Medtronic(2 entities) | 10 | $756 |
| Caldera Medical, Inc | 8 | $727 |
| Coloplast | 5 | $471 |
| Intuitive Surgical | 1 | $135 |
| Escala Medical Inc. | 1 | $16 |
| Urovant Sciences Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,630
- BOTOX$1,238
- Desara$600
- INTERSTIM$538
- Advantage System$433
- ALTIS$142
- Da Vinci Surgical System$135
- SOLYX$119
- Bulkamid$101
How this compares
$6,263 in reported general payments places this provider in the 90th percentile of 22 urogynecology and reconstructive pelvic surgery providers in Minnesota.
See all urogynecology and reconstructive pelvic surgery providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 117 | $6,985 |
| Trimethoprim | 14 | $655 |
| Cephalexin | 15 | $60 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Rochester
- John GebhartRochester$11K
- Christopher KlingeleRochester$2K
- Sujatha NarayanamoorthyRochester$2K
- Courtney PfeutiRochester$1K
- Emanuel TrabucoRochester$663
- Diana Encalada SotoRochester$561
- Morgan SteffenRochester$390
- Morgan BriggsRochester$63
- Kelsey StewartRochester$50
- Michael EhlertWoodbury$151K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.